Literature DB >> 11716825

Effects of methylmalonic and propionic acids on glutamate uptake by synaptosomes and synaptic vesicles and on glutamate release by synaptosomes from cerebral cortex of rats.

A M Brusque1, L N Rotta, R G Tavares, T Emanuelli, C V Schwarzbold, C S Dutra-Filho, A T de Souza Wyse, C M Duval Wannmacher, D O Gomes de Souza, M Wajner.   

Abstract

Neurological dysfunction is common in patients with methylmalonic and propionic acidemias. However, the mechanisms underlying the neuropathology of these disorders are far from understood. In the present study we investigated the in vitro effects of methylmalonic (MMA) and propionic (PA) acids at various concentrations (1 microM-5 mM) on three parameters of the glutamatergic system, namely the basal and potassium-induced release of L-[3H]glutamate by synaptosomes, Na+-dependent L-[3H]glutamate uptake by synaptosomes and Na+-independent L-[3H]glutamate uptake by synaptic vesicles from cerebral cortex of male adult Wistar rats. The results showed that MMA significantly increased potassium-induced but not basal L-[3H]glutamate release from synaptosomes with no alteration in synaptosomal L-[3H]glutamate uptake. A significant reduction of L-[3H]glutamate incorporation into vesicles caused by MMA was also detected. In contrast, PA had no effect on these parameters. These findings indicate that MMA alters the glutamatergic system. Although additional studies are necessary to evaluate the importance of these observations for the neuropathology of methylmalonic acidemia, it is possible that the effects elicited by MMA may lead to excessive glutamate concentrations at the synaptic cleft, a fact that may explain previous in vivo and in vitro findings associating MMA with excitotoxicity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716825     DOI: 10.1016/s0006-8993(01)03069-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Experimental evidence that methylmalonic acid provokes oxidative damage and compromises antioxidant defenses in nerve terminal and striatum of young rats.

Authors:  Carolina Gonçalves Fernandes; Clarissa Günther Borges; Bianca Seminotti; Alexandre Umpierrez Amaral; Lisiane Aurélio Knebel; Paula Eichler; Anderson Büker de Oliveira; Guilhian Leipnitz; Moacir Wajner
Journal:  Cell Mol Neurobiol       Date:  2011-03-22       Impact factor: 5.046

2.  Methylmalonic Acid Impairs Cell Respiration and Glutamate Uptake in C6 Rat Glioma Cells: Implications for Methylmalonic Acidemia.

Authors:  Renata T Costa; Marcella B Santos; Carlos Alberto-Silva; Daniel C Carrettiero; César A J Ribeiro
Journal:  Cell Mol Neurobiol       Date:  2022-06-08       Impact factor: 5.046

3.  Diffusion-weighted imaging in the assessment of neurological damage in patients with methylmalonic aciduria.

Authors:  A P Burlina; R Manara; M Calderone; S Catuogno; A B Burlina
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 4.  The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies.

Authors:  M Wajner; A Latini; A T S Wyse; C S Dutra-Filho
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

5.  Methylmalonic acid administration induces DNA damage in rat brain and kidney.

Authors:  Vanessa M Andrade; Hugo S Dal Pont; Daniela D Leffa; Adriani P Damiani; Giselli Scaini; Giana Hainzenreder; Emilio L Streck; Gustavo C Ferreira; Patrícia F Schuck
Journal:  Mol Cell Biochem       Date:  2014-02-15       Impact factor: 3.396

Review 6.  Glutathione as a Redox Biomarker in Mitochondrial Disease-Implications for Therapy.

Authors:  Gregory M Enns; Tina M Cowan
Journal:  J Clin Med       Date:  2017-05-03       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.